Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects

被引：0
|
作者：
Vitek, Grace [1 ]
Hansra, Harjot [2 ]
机构：
[1] Creighton Univ, Sch Med, Omaha, NE USA
[2] Dignity Hlth, Barrow Neurol Inst, San Francisco, CA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203811
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5-4.001
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients
    Kashiwada, Takeru
    Takano, Ryotaro
    Ando, Fumihiko
    Kuroda, Shoko
    Miyabe, Yoshishige
    Owada, Ryuji
    Miyanaga, Akihiko
    Asatsuma-Okumura, Tomoko
    Hashiguchi, Masaaki
    Kanazawa, Yoshikazu
    Yoshida, Hiroshi
    Seike, Masahiro
    Gemma, Akihiko
    Iwai, Yoshiko
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [42] A Rare Case of Dermatomyositis as Late Immune-Related Toxicity During Anti-PD1 Treatment for Advanced Lung Cancer
    Catino, A.
    Galetta, D.
    Lospalluti, L.
    Tampoia, M.
    Cazzato, G.
    Ambrogio, F.
    Montrone, M.
    Pizzutilo, P.
    Longo, V.
    Pesola, F.
    Mastrandrea, A.
    Ricci, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S642 - S643
  • [43] PD-1 immune checkpoint inhibitors and serious immune-related adverse events
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Wong, Ian C.
    Au, Philip C. -M.
    Cheung, Ching-Lung
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 293 - 293
  • [44] Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series
    Shazib, Muhammad Ali
    Woo, Sook-Bin
    Sroussi, Herve
    Carvo, Ingrid
    Treister, Nathaniel
    Farag, Arwa
    Schoenfeld, Jonathan
    Haddad, Robert
    LeBoeuf, Nicole
    Villa, Alessandro
    ORAL DISEASES, 2020, 26 (02) : 325 - 333
  • [45] Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series
    Pergolini, Daniele
    Botticelli, Andrea
    Fascetti, Roberta
    Rocchetti, Federica
    Cirillo, Alessio
    Tenore, Gianluca
    Palaia, Gaspare
    Polimeni, Antonella
    Romeo, Umberto
    APPLIED SCIENCES-BASEL, 2022, 12 (24):
  • [46] Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy
    Hsu, Shu-Jung
    Chao, Yen-Cheng
    Lin, Xia-Hui
    Liu, Hua-Hua
    Zhang, Yang
    Hong, Wei-Feng
    Chen, Mao-Pei
    Xu, Xin
    Zhang, Lan
    Ren, Zheng-Gang
    Du, Shi-Suo
    Chen, Rong-Xin
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 212 (03): : 239 - 248
  • [47] The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events
    Fujisaki, Toshiya
    Watanabe, Satoshi
    Ota, Takeshi
    Kushiro, Kohei
    Sato, Yusuke
    Takahashi, Miho
    Ohtsubo, Aya
    Shoji, Satoshi
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Hokari, Satoshi
    Kondo, Rie
    Miyabayashi, Takao
    Abe, Tetsuya
    Miura, Satoru
    Tanaka, Hiroshi
    Okajima, Masaaki
    Terada, Masaki
    Matsumoto, Naoya
    Ishida, Takashi
    Iwashima, Akira
    Sato, Kazuhiro
    Yoshizawa, Hirohisa
    Aoki, Nobumasa
    Hayashi, Masachika
    Ohshima, Yasuyoshi
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
    Delaney, Nicolas
    Michot, Jean-Marie
    Comont, Thibault
    Kramkimel, Nora
    Lazarovici, Julien
    Dupont, Romain
    Champiat, Stephane
    Chahine, Claude
    Robert, Caroline
    Herbaux, Charles
    Besse, Benjamin
    Guillemin, Aude
    Mateus, Christine
    Pautier, Patricia
    Saiag, Purippe
    Madonna, Enmauela
    Maerevoet, Marie
    Bout, Jeao-Christophe
    Leduc, Charlotte
    Biscay, Pascal
    Quere, Gilles
    Nardin, Charlee
    Ebbo, Mikael
    Albiges, Laurence
    Marret, Gregoire
    Levrat, Virginie
    Dujon, Cecile
    Vargaftig, Jacques
    Laghouati, Salim
    Croisille, Loure
    Voisin, Anne-Laure
    Godeau, Bertrand
    Massard, Christophe
    Ribrag, Vincent
    Marabelle, Aurellen
    Michel, Marc
    Lambotte, Olivier
    LANCET HAEMATOLOGY, 2019, 6 (01): : E48 - E57
  • [49] Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
    Baxi, Shrujal
    Yang, Annie
    Gennarelli, Renee L.
    Khan, Niloufer
    Wang, Ziwei
    Boyce, Lindsay
    Korenstein, Deborah
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 360
  • [50] Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic Melanoma
    Chan, Matthew M. K.
    Kefford, Richard F.
    Carlino, Matteo
    Clements, Arthur
    Manoliosz, Nicholas
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 37 - 39
12345